Modified duty.

A systematic review of the Maimonides community cancer centers in Brooklyn tells the tale of cancer treatment modifications from mid-March to mid-April as a result of the pandemic. Among 282 patients, 56% received some form of treatment modification. These occurred broadly over both curative and palliative intent therapies and even injectables with no immunosuppressive potential, presumably to avoid clinic visits. What’s more, the median age of those receiving treatment modifications (64 years) was about a decade older than those who didn’t (56 years) TBL: Further time will tell how the pandemic will shape cancer outcomes among the many who received treatment modifications. | Luin, JCO Glob Oncol 2020

Comments

Popular Posts